SYSTEMATICALLY INDIVIDUALIZING TOBRAMYCIN DOSAGE REGIMENS

被引:19
作者
CIPOLLE, RJ [1 ]
SEIFERT, RD [1 ]
ZASKE, DE [1 ]
STRATE, RG [1 ]
机构
[1] UNIV MINNESOTA,SCH MED,ST PAUL,MN 55101
关键词
D O I
10.1002/j.1552-4604.1980.tb01672.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:570 / 580
页数:11
相关论文
共 29 条
[11]   GENTAMICIN SERUM CONCENTRATIONS - PHARMACOKINETIC PREDICTIONS [J].
HULL, JH ;
SARUBBI, FA .
ANNALS OF INTERNAL MEDICINE, 1976, 85 (02) :183-189
[12]   ASPECTS OF PHARMACOLOGY AND TOXICOLOGY OF TOBRAMYCIN IN ANIMALS AND HUMANS [J].
ISRAEL, KS ;
WELLES, JS ;
BLACK, HR .
JOURNAL OF INFECTIOUS DISEASES, 1976, 134 :S97-S103
[13]  
KEYS TF, 1977, MAYO CLIN PROC, V52, P797
[14]  
KOCH KF, 1971, ANTIMICROB AGENTS CH, P309
[15]   INCREASED GLOMERULAR-FILTRATION RATE IN PATIENTS WITH MAJOR BURNS AND ITS EFFECT ON PHARMACOKINETICS OF TOBRAMYCIN [J].
LOIRAT, P ;
ROHAN, J ;
BAILLET, A ;
BEAUFILS, F ;
DAVID, R ;
CHAPMAN, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (17) :915-919
[16]   CORRELATION OF PREDICTED VERSUS MEASURED CREATININE CLEARANCE VALUES IN BURN PATIENTS [J].
LOTT, RS ;
UDEN, DL ;
WARGIN, WA ;
STRATE, RG ;
ZASKE, DE .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1978, 35 (06) :717-720
[17]   EMERGENCE OF GENTAMICIN-RESISTANT BACTERIA - EXPERIENCE WITH TOBRAMYCIN THERAPY OF INFECTIONS DUE TO GENTAMICIN-RESISTANT ORGANISMS [J].
MOELLERING, RC ;
WENNERSTEN, C ;
KUNZ, LJ .
JOURNAL OF INFECTIOUS DISEASES, 1976, 134 :S40-S49
[18]   PHARMACOKINETICS OF AMINOGLYCOSIDE ANTIBIOTIC TOBRAMYCIN IN HUMANS [J].
NABER, KG ;
WESTENFELDER, SR ;
MADSEN, PO .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1973, 3 (04) :469-473
[19]   TOBRAMYCIN - OVERVIEW [J].
NEU, HC .
JOURNAL OF INFECTIOUS DISEASES, 1976, 134 :S3-S19
[20]   EXPERIENCE IN MONITORING GENTAMICIN THERAPY DURING TREATMENT OF SERIOUS GRAM-NEGATIVE SEPSIS [J].
NOONE, P ;
PARSONS, TMC ;
PATTISON, JR ;
SLACK, RCB ;
GARFIELD.D ;
HUGHES, K .
BRITISH MEDICAL JOURNAL, 1974, 1 (5906) :477-481